ACI today publicly rebuts the content and claims made in a letter published and shared widely on social media on Friday 26 March 2021.
Experts from the Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) have put together a detailed safety review paper of THC – Health Guidance Levels for THC in CBD products: Safety Assessment & Regulatory Recommendations. The paper recommends further research and makes policy recommendations.
ACI Forms Exclusive Partnership with PR Agency Ingredient Communications to Offer B2B Comms Support for Members
Today ACI announced an exclusive partnership with the UK’s leading PR agency specialising in B2B communications in the food and nutrition sectors, Ingredient Communications.
ACI welcomes the recent update from the UK’s Food Standards Agency concerning the criteria of which CBD products can remain on sale in the UK as of 1st April 2021.
ACI have submitted their novel food application on behalf of the members of our CBD Safety Study Consortium. This marks a pivotal milestone for the ACI, whose members have been diligently working to meet the compliance deadline set by the UK’s Food Standards Agency (FSA).
ACI today announces it is the first UK cannabis industry association to formalise a partnership with Trading Standards. This agreement was approved by the Secretary of State last week.
With the European Commission (EC) stating that they will begin assessing novel food dossiers on CBD again, ACI started 2021 by engaging the EC in constructive dialogue regarding our consortium approach to novel food applications.
ACI’s responds to a recent letter from Kit Malthouse MP, the Minister of State for Crime and Policing, to Professor Owen Bowden-Jones, the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
On 31 March 2021, guidelines set by the UK Foods Standards Agency (FSA) will come into effect and transform the CBD market, which is projected to be worth £1billion by 2025. In this 9 minutes long video you will learn from the experts in this space.
Food Standards Scotland (FSS) clarified their position in relation to CBD in food products to the ACI. They emphasised, from a legal perspective, ingredients which are classified as novel foods are not permissible on the market until they have a full novel foods authorisation. However, they support a proportionate response by local authorities based on a companies commitment to gaining novel foods authorisation.